> Boston is the world-center of biotech startups and VC
Beijing is likely far ahead. Beijing's total VC investment is much higher, it accounts for over 1/3 of Chinese domestic VC and Chinese firms have accounted for over 40% of the biotech investment in US drug startups in the beginning of this year.
Beijing is likely far ahead. Beijing's total VC investment is much higher, it accounts for over 1/3 of Chinese domestic VC and Chinese firms have accounted for over 40% of the biotech investment in US drug startups in the beginning of this year.
https://www.bloomberg.com/news/articles/2018-04-18/chinese-m...